HealthTech, biotech, and digital therapeutic startups typically feature co-founding teams with contrasting backgrounds, often combining practicing medical doctors or academic researchers with software developers and business executives. A standard, off-the-shelf founders agreement is entirely inadequate to manage these complex partnerships. A specialized healthcare founders agreement clearly outlines intellectual property assignments, vesting schedules, regulatory compliance responsibilities, and decision-making protocols for clinical trials and medical safety, ensuring the company remains stable and investor-ready.
A robust Founders Agreement is the critical baseline for any scaling startup, codifying co-founder equity splits, reverse vesting schedules, intellectual property transfer, and clear decision-making frameworks. Drafted under the Indian Contract Act, 1872, this strategic contract defines executive roles, protects company equity from early-departure dilution via milestone-based cliffs, and establishes practical deadlock resolution protocols. By formalizing partner departures and asset control pre-incorporation, it prevents costly corporate litigation, ensures a clean cap table, and establishes the strict legal hygiene required by institutional investors for upcoming venture capital rounds.
Medical co-founders often conduct early research at research universities, public laboratories, or hospital networks, creating a high risk of conflicting intellectual property claims. A specialized founders agreement includes strict IP assignment clauses, guaranteeing that all clinical designs and algorithms are owned solely by the startup and are free from institutional claims.
Unlike standard software startups, healthcare ventures scale based on prolonged regulatory approvals, such as clinical trial phases or CE and FDA clearances. Structured founders agreements align equity vesting schedules with these specific regulatory and clinical milestones, keeping the founding team incentivized and aligned through the multi-year development cycle of the medical product.
Protects core equity from early-departure dilution by establishing a structured four-year vesting timeline with a strict one-year cliff.
Guarantees all software, designs, and innovations developed by co-founders are legally transferred to the corporate entity, securing asset ownership.
Establishes a clear, tiered dispute resolution protocol to resolve operational disagreements at the board level without paralyzing company progress.
Outlines clear share buyback guidelines and valuation rules for exiting partners, preventing cap table fragmentation.
Vesting ensures that co-founders earn their equity over time, typically four years with a one-year cliff. If a founder departs early, the unvested equity remains with the company or is clawed back, preventing inactive partners from holding large portions of corporate shares.
The IP assignment clause legally transfers ownership of all product concepts, software code, and business intellectual property from the individual co-founders to the company itself. This ensures the startup holds absolute title to its core assets, which is a mandatory requirement for venture capital due diligence.
Yes, a Founders Agreement executed on appropriate non-judicial stamp paper and signed by all co-founders is a legally binding contract under the Indian Contract Act, 1872. It governs founder relations pre-incorporation and can be incorporated into the company's Articles of Association post-incorporation.
Comprehensive solutions tailored perfectly to your industry.
Incorporate a Private Limited Company to secure limited liability, build investor trust, and establish a scalable corporate structure.
